Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CI
CI logo

CI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
293.000
Open
290.390
VWAP
289.69
Vol
1.70M
Mkt Cap
76.47B
Low
287.000
Amount
491.26M
EV/EBITDA(TTM)
7.33
Total Shares
264.53M
EV
99.48B
EV/OCF(TTM)
11.29
P/S(TTM)
0.28
The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.
Show More

Events Timeline

(ET)
2026-04-30
06:10:00
Cigna Group Expects 2026 Adjusted EPS of At Least $30.35
select
2026-04-30
06:10:00
Cigna Group Q1 Revenue $68.49B Beats Expectations
select
2026-04-29 (ET)
2026-04-29
14:40:00
Notable Companies Reporting Earnings Before Tomorrow's Open
select

News

Yahoo Finance
9.5
05-06Yahoo Finance
Cigna Group Rated Among Top Fortune 500 Stocks
  • Strong Earnings Beat: Cigna Group reported an adjusted EPS of $7.79 for Q1 2023, reflecting a 16% year-over-year growth, while revenue reached $68.5 billion, up 4.7%, indicating robust financial performance that boosts market confidence in future growth.
  • Price Target Increase: Barclays raised Cigna's price target from $303 to $310, maintaining an 'Overweight' rating, which represents an almost 10% upside from current levels, reflecting analysts' optimistic outlook on the company's future performance.
  • Exit from Subsidized Plans: Cigna announced its exit from subsidized plans under the Affordable Care Act by year-end, a strategic decision that may impact market share but aims to optimize its product portfolio and enhance overall profitability.
  • Upgraded Full-Year Outlook: Cigna raised its full-year 2026 consolidated adjusted EPS outlook to at least $30.35, up from the previous guidance of $30.25 and slightly above the consensus of $30.33, demonstrating the company's confidence in its future earnings.
CNBC
7.5
05-05CNBC
Amazon's New Logistics Initiative Shakes Market
  • Increased Market Competition: Amazon's announcement of a new initiative allowing external businesses to utilize its supply chain for deliveries led to significant stock declines for UPS and FedEx, dropping over 10% and 9% respectively, indicating investor concerns about intensified competition in the logistics sector.
  • Strong Sales Growth: Palantir reported an impressive 85% revenue growth in Q1, with net income approximately quadrupling year-over-year, showcasing its robust performance in the defense technology sector and projecting a doubling of its U.S. business in the coming year.
  • Tesla and SEC Settlement: Tesla CEO Elon Musk reached a settlement with the SEC, agreeing to pay $1.5 million in penalties over allegations of failing to disclose his Twitter stake prior to acquisition, although this minor fine is not expected to have a significant financial impact on the company.
  • GLP-1 Market Dynamics: Novo Nordisk's Wegovy pill has rapidly gained tens of thousands of new users within four months of launch, while Eli Lilly's competing Foundayo has seen a more modest uptake, reflecting a shift in market demand for weight-loss medications.
Newsfilter
7.5
05-05Newsfilter
Amazon's New Logistics Initiative Shakes Market
  • Market Uncertainty Intensifies: Rising tensions in the Middle East have led to surging oil prices, causing the Dow Jones Industrial Average to drop over 550 points on Monday, marking its worst performance in more than a month, which has left investors concerned about future market sentiment.
  • Palantir Surpasses Expectations: Palantir reported an 85% revenue growth in Q1, with net income nearly quadrupling year-over-year, and anticipates its U.S. business will double again next year, raising its full-year free cash flow guidance to $4.2 billion to $4.4 billion, indicating strong market demand and growth potential.
  • Tesla Settles with SEC: Tesla CEO Elon Musk has agreed to pay $1.5 million to the SEC to settle allegations of failing to disclose his stake in Twitter before its acquisition, which, if approved by the judge, could alleviate legal risks for Musk and potentially have a positive impact on Tesla's stock price.
  • Amazon's New Logistics Initiative: Amazon announced a new initiative allowing external businesses to utilize its supply chain networks for deliveries, which has raised concerns about increased competition with UPS and FedEx, leading to stock declines of over 10% and 9% respectively, reflecting market apprehension about the new competitive landscape.
CNBC
9.5
05-05CNBC
Health Insurers Show Strong Q1 Performance Amid Cost Challenges
  • Strong Q1 Results: Major health insurers like UnitedHealth, Elevance, Cigna, and Humana exceeded expectations, boosting investor sentiment despite rising medical costs, reflecting effective strategies in pricing and cost control.
  • Increased Medical Reserves: Analysts noted that insurers have strengthened medical reserves, providing a cushion for future claims, a strategy that could imply positive earnings implications for 2026, although the real data from Q2 remains crucial.
  • Market Adjustment Strategies: Companies have successfully reduced medical loss ratios by exiting unprofitable markets and adjusting pricing and benefits of medical plans, demonstrating effective responses to increased demand for medical services post-pandemic, thereby enhancing market competitiveness.
  • Critical Future Outlook: The second quarter will serve as a true test for insurers, as more claims data becomes available, investors will closely monitor medical loss ratios and changes in full-year outlooks to assess whether companies can sustain current growth momentum.
CNBC
8.5
05-04CNBC
Sierra Raises Nearly $1 Billion Amid Intensifying AI Market Competition
  • Record Funding Round: Sierra has raised $950 million in its latest funding round, achieving a post-money valuation of $15.8 billion, which underscores the strong interest and confidence from investors in the AI sector, particularly in a rapidly intensifying competitive landscape.
  • Rapid Revenue Growth: The company surpassed $150 million in annual recurring revenue (ARR) within eight quarters, a growth trajectory unprecedented in traditional software, highlighting the intense market demand for its AI customer service agents.
  • Significant Market Opportunity: Taylor estimates that $400 billion is spent annually on customer service, and as enterprises increasingly shift towards AI agents, Sierra is positioned to capitalize on this substantial market opportunity by offering more efficient service experiences.
  • Strategic Expansion Plans: With the new funding, Sierra aims to solidify its market leadership; Taylor noted that despite fierce competition, the company is multiples larger than its nearest rivals and will continue to invest aggressively to maintain its competitive edge.
Newsfilter
8.5
05-04Newsfilter
AI Startup Sierra Raises $950 Million in Series E Funding
  • Record Funding Round: Sierra raised $950 million in its latest funding round, pushing its valuation from $10 billion to $15.8 billion, highlighting investors' strong interest in the AI sector and their pursuit of emerging market leaders.
  • Diverse Clientele: The startup serves major enterprises like Prudential, Cigna, Blue Cross Blue Shield, and Rocket Mortgage, reaching over 40% of Fortune 50 companies, which underscores its market leadership in AI customer service.
  • Rapid Revenue Growth: Sierra achieved over $150 million in annual recurring revenue (ARR) within eight quarters, an unprecedented growth rate in traditional software, reflecting intense market demand for its offerings.
  • Expansive Market Potential: Founder Bret Taylor estimates that $400 billion is spent annually on customer service, and as AI agents become more prevalent, Sierra is focused on maintaining its competitive edge in an increasingly crowded market.
Wall Street analysts forecast CI stock price to rise
16 Analyst Rating
Wall Street analysts forecast CI stock price to rise
14 Buy
2 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Current: 0.000
sliders
Low
300.00
Averages
335.63
High
378.00
Bernstein
Lance Wilkes
Outperform
maintain
$358 -> $371
AI Analysis
2026-05-05
Reason
Bernstein
Lance Wilkes
Price Target
$358 -> $371
AI Analysis
2026-05-05
maintain
Outperform
Reason
Bernstein analyst Lance Wilkes raised the firm's price target on Cigna to $371 from $358 and keeps an Outperform rating on the shares following quarterly results. The firm is updating its earnings model with EPS estimates roughly the same for 2026, and modestly higher for 2027 - 2030.
Mizuho
Outperform
maintain
$325 -> $330
2026-05-01
Reason
Mizuho
Price Target
$325 -> $330
2026-05-01
maintain
Outperform
Reason
Mizuho raised the firm's price target on Cigna to $330 from $325 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CI
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cigna Group (CI.N) is 9.07, compared to its 5-year average forward P/E of 10.72. For a more detailed relative valuation and DCF analysis to assess Cigna Group's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.72
Current PE
9.07
Overvalued PE
11.89
Undervalued PE
9.55

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
8.88
Current EV/EBITDA
5.19
Overvalued EV/EBITDA
9.81
Undervalued EV/EBITDA
7.95

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.39
Current PS
0.25
Overvalued PS
0.46
Undervalued PS
0.31

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what sector is undervalued right now
Intellectia · 90 candidates
Market Cap Category: small, mid, large, megaRelative Vol: >= 1.50Pe Ttm: <= 15Ps Ratio: <= 3.00P/B Ratio: <= 3.00Ev Ebitda: <= 12
Ticker
Name
Market Cap$
top bottom
SHEL logo
SHEL
Shell PLC
248.20B
SONY logo
SONY
Sony Group Corp
116.85B
CI logo
CI
Cigna Group
77.07B
NTES logo
NTES
NetEase Inc
72.42B
VALE logo
VALE
Vale SA
67.67B
ACGL logo
ACGL
Arch Capital Group Ltd
32.72B
top stocks in health sector
Intellectia · 38 candidates
Market Cap: >= 10.00BSector: Healthcare, Healthcare Services & EquipmentIndustry: Biotechnology & Medical Research, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 5List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 10.0%
Ticker
Name
Market Cap$
top bottom
LLY logo
LLY
Eli Lilly and Co
866.87B
ABBV logo
ABBV
AbbVie Inc
364.65B
AZN logo
AZN
AstraZeneca PLC
293.00B
MRK logo
MRK
Merck & Co Inc
282.35B
UNH logo
UNH
UnitedHealth Group Inc
254.55B
AMGN logo
AMGN
Amgen Inc
188.63B
give me a selection of long term stocks
Intellectia · 27 candidates
Market Cap: >= 50.00BRevenue 5yr Cagr: >= 8Pe Ttm: 12 - 30Return On Equity: >= 13.0%Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
META logo
META
Meta Platforms Inc
1.66T
JPM logo
JPM
JPMorgan Chase & Co
775.45B
MU logo
MU
Micron Technology Inc
471.24B
MRK logo
MRK
Merck & Co Inc
287.32B
MS logo
MS
Morgan Stanley
255.47B
GS logo
GS
Goldman Sachs Group Inc
244.45B
name me one concrete stock to buy
Intellectia · 28 candidates
Market Cap: >= 10.00BRegion: USQuarter Revenue Yoy Growth: >= 10.0%Pe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Is Index Component: GSPCOne Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
DE logo
DE
Deere & Co
163.44B
FE logo
FE
FirstEnergy Corp
28.94B
CTRA logo
CTRA
Coterra Energy Inc
23.80B
MPWR logo
MPWR
Monolithic Power Systems Inc
57.06B
PKG logo
PKG
Packaging Corp of America
22.16B
HUBB logo
HUBB
Hubbell Inc
27.86B
stocks to look into tmr
Intellectia · 9 candidates
Relative Vol: >= 2Is Index Component: GSPCOne Day Rise Prob: >= 55Monthly Average Dollar Volume: >= 5,000,000
Ticker
Name
Market Cap$
top bottom
WAB logo
WAB
Westinghouse Air Brake Technologies Corp
41.66B
ROK logo
ROK
Rockwell Automation Inc
47.41B
EBAY logo
EBAY
eBay Inc
39.08B
IR logo
IR
Ingersoll Rand Inc
38.97B
KKR logo
KKR
KKR & Co Inc
91.54B
EXPE logo
EXPE
Expedia Group Inc
28.41B
which stocks should I buy?
Intellectia · 68 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Beta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
Can you add a screener for me?A I
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B
insiders buying in last 30 days
Intellectia · 505 candidates
Insider Transactions: NetPurchase
Ticker
Name
Market Cap$
top bottom
GE logo
GE
General Electric Co
335.96B
LIN logo
LIN
Linde PLC
205.15B
SPGI logo
SPGI
S&P Global Inc
160.84B
ETN logo
ETN
Eaton Corporation PLC
131.26B
SBUX logo
SBUX
Starbucks Corp
109.65B
NKE logo
NKE
Nike Inc
96.83B
select 5 stocks with strong buy rating
Intellectia · 90 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong BuyPe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
BAC logo
BAC
Bank of America Corp
375.55B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
RY logo
RY
Royal Bank of Canada
235.24B
ABT logo
ABT
Abbott Laboratories
209.93B
DIS logo
DIS
Walt Disney Co
202.08B
C logo
C
Citigroup Inc
198.97B
¿Qué acción debería invertir sí o si
Intellectia · 69 candidates
Market Cap: >= 10.00BDividend Yield Ttm: >= 2Revenue 5yr Cagr: >= 5Pe Ttm: <= 20
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
563.46B
UNH logo
UNH
UnitedHealth Group Inc
315.01B
MS logo
MS
Morgan Stanley
290.20B
NVO logo
NVO
Novo Nordisk A/S
263.42B
RY logo
RY
Royal Bank of Canada
235.24B
GILD logo
GILD
Gilead Sciences Inc
160.18B

Whales Holding CI

S
Simplex Trading, LLC
Holding
CI
+67.62%
3M Return
M
Mubadala Investment Company PJSC
Holding
CI
+51.45%
3M Return
W
Wolverine Trading, LLC
Holding
CI
+23.18%
3M Return
W
Walleye Capital LLC
Holding
CI
+18.85%
3M Return
B
Bridgewater Associates
Holding
CI
+16.31%
3M Return
O
Osmosis Investment Management UK Limited
Holding
CI
+16.22%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cigna Group (CI) stock price today?

The current price of CI is 289.07 USD — it has increased 0.35

What is Cigna Group (CI)'s business?

The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.

What is the price predicton of CI Stock?

Wall Street analysts forecast CI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CI is335.63 USD with a low forecast of 300.00 USD and a high forecast of 378.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cigna Group (CI)'s revenue for the last quarter?

Cigna Group revenue for the last quarter amounts to 68.49B USD, increased 4.57

What is Cigna Group (CI)'s earnings per share (EPS) for the last quarter?

Cigna Group. EPS for the last quarter amounts to 6.26 USD, increased 29.07

How many employees does Cigna Group (CI). have?

Cigna Group (CI) has 67700 emplpoyees as of May 12 2026.

What is Cigna Group (CI) market cap?

Today CI has the market capitalization of 76.47B USD.